Revised NMR assignments for the cholecystokinin antagonist asperlicin.
Sun
H H
HH
Sterling Winthrop Pharmaceuticals Research Division, Malvern, Pennsylvania 19355.
Byard
S J
SJ
Cooper
R
R
D001570:Benzodiazepinones / Q000737:chemistry*; D002766:Cholecystokinin / Q000037:antagonists & inhibitors*; D009682:Magnetic Resonance Spectroscopy
D001570:Benzodiazepinones; D002766:Cholecystokinin; C046367:asperlicin